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Abstract
Background: Commensal bacteria represent an important reservoir of antibiotic resistance genes. Few community-
based studies of antibiotic resistance in commensal bacteria have been conducted in Southeast Asia. We
investigated the prevalence of resistance in commensal Escherichia coli in preschool children in rural Vietnam, and
factors associated with carriage of resistant bacteria.
Methods: We tested isolates of E. coli from faecal samples of 818 children aged 6-60 months living in FilaBavi, a
demographic surveillance site near Hanoi. Daily antibiotic use data was collected for participating children for three
weeks prior to sampling and analysed with socioeconomic and demographic characteristics extracted from
FilaBavi’s re-census survey 2007. Descriptive statistics were generated, and a logistic regression model was used to
identify contributions of the examined factors.
Results: High prevalences of resistance were found to tetracycline (74%), co-trimoxazole (68%), ampicillin (65%),
chloramphenicol (40%), and nalidixic acid (27%). Two isolates were resistant to ciprofloxacin. Sixty percent of
isolates were resistant to three or more antibiotics. Recent sulphonamide use was associated with co-trimoxazole
resistance [OR 3.2, 95% CI 1.8-5.7], and beta-lactam use with ampicillin resistance [OR 1.8, 95% CI 1.3-2.4]. Isolates
from children aged 6-23 months were more likely to be resistant to ampicillin [OR 1.8, 95% CI 1.3-2.4] and co-
trimoxazole [OR 1.5, 95% CI 1.1-2.0]. Associations were identified between geographical areas and tetracycline and
ampicillin resistance.
Conclusions: We present high prevalence of carriage of commensal E. coli resistant to commonly used antibiotics.
The identified associations with recent antibiotic use, age, and geographical location might contribute to our
understanding of carriage of antibiotic resistant commensal bacteria.
Background
The growing problems posed by antibiotic resistance
continue to be recognised and reported on [1-4]. Rising
antibiotic resistance leads to increased mortality and
morbidity, enhanced transmission of resistant bacteria,
and increased health costs [2]. The European Centre for
Disease Prevention and Control estimates that antibiotic
resistance caused at least 25,000 deaths in Europe in
2007, which was over half the annual number of deaths
caused by road traffic incidents in the same countries
[5].
The mechanisms that produce antibiotic resistance are
coded for in genes, which may be located on bacterial
chromosomes or on mobile elements that may pass
between different bacteria, such as plasmids [6]. An
important reservoir of antibiotic resistance genes is
found in commensal bacteria, which are further capable
of facilitating the spread of such genes to pathogenic
strains of bacteria [7,8]. The largest population of com-
mensal bacteria is that found in the gut, where they are
at risk of exposure to orally ingested antibiotics, as well
as certain parenteral preparations [9].
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bacteria have used clinical pathogens or commensal bac-
teria from people in healthcare settings. Data on resis-
tance in commensal bacteria isolated from community
settings have been reported on less frequently, especially
so from Southeast Asia, where the findings have consis-
tently shown high prevalences of resistance [9-12].
The most important determinant of the emergence of
bacterial antibiotic resistance, both in individuals and
populations, is antibiotic use [13]. In community set-
tings young children tend to be the most exposed to
antibiotics, and several studies have found that younger
children have the highest risk of carrying resistant com-
mensal bacteria [11,14]. Escherichia coli, a near ubiqui-
tous coloniser of the gastrointestinal tract in children
and adults, has often been used in studies of resistance
in commensal bacteria [11,15-17]. E. coli has been
shown to develop resistance in response to antibiotic
use, and to be particularly capable of exchanging anti-
biotic resistance genes with pathogenic bacteria [7,18].
Recently, a number of other factors associated with car-
riage of resistant commensal organisms have been
reported, but the various contributions of these remains
unclear [15,16].
The aim of our study was to investigate the prevalence
of resistance to antibiotics in commensal E. coli carried
by preschool children in the population of a rural area
of North Vietnam, and to further examine whether anti-
biotic use and a number of demographic and socioeco-
nomic variables were associated with carriage of
resistant E. coli. This study is part of a larger project
c o n d u c t e di nar u r a la r e ai nn o r t h e r nV i e t n a mw h e r e
data have been collected on perceptions of child care-
givers regarding antibiotic use [19], knowledge and prac-
tice of healthcare providers [20], prevalence of antibiotic
resistance in Streptococcus pneumoniae [21] and
reported antibiotic use [22].
Materials and methods
Study area
The study was carried out in Bavi district, 60 km west of
Hanoi, Vietnam. The population of the region is
approximately 250,000 persons, living in lowland, high-
land and mountainous areas. Children under five years
of age account for 8% of the population. The public
health care system consists of a 150 bed district hospital,
3 regional polyclinics and 32 commune health stations.
There are also more than 200 private providers in the
region, including private clinics, private pharmacies and
traditional healers. The FilaBavi Epidemiological Field
Laboratory was established in Bavi in 1998 [23]. Baseline
and re-census surveys have been carried out every sec-
ond year, with follow-up of vital events conducted every
three months. FilaBavi is divided into units, referred to
as clusters, with around 600-700 inhabitants in each
cluster. In total there are 69 clusters within FilaBavi,
including around 51,000 inhabitants and 12,000
households.
Subjects and sample size
A sufficient number of clusters were included from each
geographical area (lowland, highland, mountainous) to
reach the total calculated sample size. This calculation
was based on the finding from a previous study that
70% of children under five in the community used anti-
biotics during one month [24], with an expected drop
out of 30%, and a design effect of 2.0 due to clustering.
All of the households in the largest clusters within each
geographical area were selected to include about 280
households in each area. Between March and June 2007
a total sample of 847 children was selected from 847
households in which at least one child was eligible for
the study. One child aged 6-60 months at the time of
study was randomly selected within each household that
had more than one child fulfilling the inclusion criteria,
using a computer. Data were extracted from FilaBavi’s
r e - c e n s u ss u r v e y2 0 0 7o nt h ep a r t i c i p a n t s ’ characteris-
tics, date of birth, sex, residential areas, parents’ educa-
tion and households’ assets, expenditure and income.
Survey of drug use and sampling of isolates
Interviews with structured questionnaires were con-
ducted weekly with the main child-caregiver in the
household in order to collect information on reported
daily illness symptoms and drug use for the participating
child over a four-week period. Caregivers were
requested to complete a form detailing daily drug use
for the child. If available, the prescription or drug pack-
age was checked by the interviewers. Drugs used were
classified according to the Anatomical Therapeutic Che-
mical (ATC) classification system [25] with the assis-
tance of VN-pharmacy software [26]. This study
includes only antibiotics classified as antibacterials for
systemic use. These are aggregated at the level of the
active ingredient (level 5 of the ATC class J01) [25].
Children were invited to attend the health commune
station for a clinical examination on the 21st day of par-
ticipation in the study. This was conducted by paediatri-
cians from district or central hospitals. Faecal samples
were collected by trained microbiologists, and immedi-
ately placed in a Cary-Blair transport tube. Within 12 h
of sampling, all specimens reached the Clinical Labora-
tories of the National Institute of Infectious and Tropi-
cal Diseases, Hanoi.
E. coli was isolated and identified using standard
laboratory procedures [27]. Briefly, presumptive E. coli
isolates were picked based on typical colony morphology
and Gram staining. Identification was confirmed by API
Dyar et al. BMC Infectious Diseases 2012, 12:92
http://www.biomedcentral.com/1471-2334/12/92
Page 2 of 820E strip test (bioMérieux, France). E. coli serotyping
was conducted following a protocol previously described
[28], with the minor modification that the multiplex
PCR assay was carried out on DNA extracted from a
smear of bacteria from the first area of a MacConkey
plate. Separate to this, a single colony was selected and
sub-cultured for purity check and antibacterial suscept-
ibility testing. The serotyping was conducted using a
smear of colonies, whereas the antibiotic susceptibility
testing used a single colony. Therefore it cannot be
assumed that where diarrhoeagenic strains were found
to be carried by a child that it was a colony of the same
strain that also underwent susceptibility testing.
Antibacterial susceptibility testing
For all isolates, inhibitory zone diameters were measured
for tetracycline, co-trimoxazole, ampicillin, chloramphe-
nicol and nalidixic acid using disk diffusion (BIO-RAD
Laboratories, Marnes-la-Coquette, France). Minimum
inhibitory concentrations were determined for ciproflox-
acin using Etest (AB bioMérieux, Solna, Sweden, for-
merly AB BIODISK) for all isolates except for nine that
did not survive storage. The antibiotics tested were
those recommended for testing by the Clinical and
Laboratory Standards Institute (CLSI) [29]. Susceptibility
testing was carried out according to the performance
standards of CLSI and the technical instructions of
manufacturers. E. coli ATCC 25922 was used as the
c o n t r o ls t r a i ni ns u s c e p t i b i l i ty tests. Testing conditions
and reading of the diameter of the inhibitory zones and
the MICs followed CLSI guidelines.
Interpretative breakpoints were based on the 2010
CLSI standards for this paper [30]. Susceptible or inter-
mediately susceptible isolates were categorized as sus-
ceptible. Decreased susceptibility of isolates to the tested
antibiotics was also determined using the epidemiologi-
cal cut-off values (ECOFF) defined by the European
Committee on Antimicrobial Susceptibility Testing
(EUCAST) [31].
Statistical analysis
Frequencies and proportions of isolates resistant to the
tested antibiotics were calculated. A two stage process was
used to determine associations with the outcome measures
of (i) resistance to any antibiotic, and (ii) resistance to a
specific antibiotic. The variables were first tested for asso-
ciation in univariate analysis using chi-square test, with
those approaching statistical significance then entered into
the binomial logistic regression model with backward
selection. The independent variables assessed were: sex
(male vs. female), age (6-23 months vs. 24-60 months),
presence of diarrhoea (yes vs. no), economic status of the
household (average or above vs. below average), number
of children aged 0-17 living in household (one vs. more
than one), area (lowland, highland vs. mountains),
reported antibiotic use of any antibiotic class within the
three weeks preceding the sample collection day (yes/no)
and use of a specific class of antibiotic within the three
weeks preceding the sample collection day (J01C, J01D,
J01E, J01F). All statistical analyses were conducted using
PASW Statistics 18.0 (SPSS Inc., Chicago, IL, USA), with a
significance level of p = 0.05.
Ethical considerations
Approval for the study was received from the ethical
review board of Hanoi Medical University (No 28/
HMURB, 2006). Permission for the study and use of
census data was received from the FilaBavi steering
committee. All parents were asked for verbal consent
after explanation of the purpose and methods of the
study. Confidentiality was assured, and participants were
made aware of their right to withdraw at any time in
the study period without explanation. Children identi-
fied at clinical examination as having need of medical
care were treated and counselled by the paediatricians
from the district or central hospitals.
Results
Study population
Of the 847 selected children, 818 (99%) caregivers con-
sented for their child to participate in the clinical exami-
nation and collection of faecal samples. The
characteristics of the children are shown in Table 1.
E. coli serotypes
All 818 samples were analysed to detect the E. coli sero-
types present. Non-diarrhoeagenic E. coli were found in
738 (90%) isolates. The most common diarrhoeagenic
subtype was enterohaemorrhagic E. coli (EHEC), identi-
fied in 42 (5%) samples. Enteroaggregative E. coli was
found in 28 (3%) samples, enterotoxigenic E. Coli in 26
(3%) samples, enteropathogenic E. coli in 12 (1%) sam-
ples, and enteroinvasive E. coli in one sample.
Resistance to single and multiple antibiotics
Only 46 isolates (6%) were sensitive to all antibiotics
tested. Prevalences of resistance to single and multiple
antibiotics are presented in Table 2. The distribution of
zone diameter and MIC values are shown in Figure 1.
Resistance to multiple antibiotics was very common,
with 60% isolates resistant to three or more antibiotics
tested. The modal value was resistance to four antibio-
tics. The most common patterns of resistance to multi-
ple drugs were to tetracycline and co-trimoxazole (57%
isolates), to co-trimoxazole and ampicillin (54% isolates),
and to tetracycline and ampicillin (53% isolates). Com-
bined resistance to tetracycline, co-trimoxazole, ampicil-
lin and chloramphenicol was found in 25% isolates.
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Binomial logistic regression models were used to iden-
tify demographic, socioeconomic, and antibiotic use
associations with resistance to any antibiotics tested,
and to individual antibiotics (with the exception of
ciprofloxacin due to the low number of isolates with
ciprofloxacin resistance). Comparison prevalences for
selected variables are shown in Table 3. Isolates taken
from children aged 6-23 months were associated with
resistance to ampicillin [OR 1.8, 95% CI 1.3-2.4], co-tri-
moxazole [OR 1.5, 95% CI 1.1-2.0], and chloramphenicol
[OR 1.3, 95% CI 1.0-1.8]. Isolates from children living in
the lowland area were less likely to be resistant to tetra-
cycline [OR 0.62, 95% CI 0.42-0.90]. No association was
found between antibiotic resistance and socioeconomic
class, number of children living in the household, or
presence of diarrhoea symptoms at time of sampling.
Analysis of antibiotic use in the logistic regression
models was restricted to the antibiotics most commonly
used during the study period, beta-lactams, sulphona-
mides and antibiotics of the J01F class. Children that
had taken sulphonamides were more likely to carry E.
coli resistant to co-trimoxazole [OR 3.2, 95% CI 1.8-5.7],
and resistant to nalidixic acid [OR 1.8, 95% CI 1.2-2.8].
Prior use of beta-lactam antibiotics was associated with
carriage of E. coli resistant to any antibiotic tested [OR
2.3, 95% CI 1.3-4.0], resistant to ampicillin [OR 1.8, 95%
CI 1.3-2.4], and resistant to chloramphenicol [OR 1.3,
95% CI 1.0-1.8]. Children that had taken antibiotics of
the J01F class (macrolides, lincosamides and streptogra-
mins) were more likely to carry E. coli that tested resis-
tant to ampicillin [OR 2.1, 95% CI 1.1-4.1] and nalidixic
acid [OR 1.7, 95% CI 1.0-3.0]. Children that used sul-
phonamides in the seven days prior to sampling only, or
between eight and twenty-one days prior to sampling,
had significantly higher carriage of E. coli isolates resis-
tant to co-trimoxazole than children that did not take
any sulphonamides during the study period (95% and
86% vs. 66%). Similarly, children that used beta-lactams
exclusively in the seven days prior to sampling, or
between eight and twenty-one days prior to sampling,
were significantly more likely to carry isolates resistant
to ampicillin (74% and 70% vs. 58%).
Epidemiological cut-off analysis
For each antibiotic tested, zone diameters or MIC values
were analysed using EUCAST epidemiological cut-off
(ECOFF) values, in addition to using the clinical CLSI
criteria. The ECOFF values identify bacteria that exhibit
reduced susceptibility to antibiotics as compared with
the wildtype population. Decreased susceptibility,
Table 1 Selected sociodemographic characteristics of
participating rural children aged 6-60 months from
FilaBavi, Vietnam
Characteristics Participating children n =
818 (%)
Sex Female 373 (46)
Male 445 (54)
Age 6-23 months 367 (45)
24-60
months
451 (55)
Geographical area Lowland 268 (33)
Highland 275 (34)
Mountains 275 (34)
Household economic
status
Below
average
337 (46)
Average or
above
441 (54)
Number of children in
household
One 219 (27)
More than
one
599 (73)
Diarrhoea Present 10 (01)
Not present 808 (99)
Reported antibiotic use
in 21 days
before sampling
Yes 477 (58)
No 341 (42)
Table 2 Resistance prevalence to tested antibiotics
among 818 isolates of E.coli from children aged 6-60
months in FilaBavi, Vietnam
Antibiotic(s) tested Prevalence of resistance % (n, total n
= 818)
TET 74 (609)
SXT 68 (559)
AMP 65 (533)
CHL 40 (325)
NAL 27 (220)
CIP < 1 (2)
TET + SXT 57 (468)
TET + AMP 52 (424)
TET + CHL 34 (275)
TET + NAL 20 (164)
SXT + AMP 54 (441)
SXT + CHL 34 (277)
SXT + NAL 23 (185)
AMP + CHL 33 (270)
AMP + NAL 18 (151)
CHL + NAL 13 (109)
TET + SXT + AMP 45 (368)
TET + SXT + AMP + CHL 25 (208)
TET + SXT + AMP + CHL +
NAL
8 (68)
Abbreviations used: TET = tetracycline; SXT = co-trimoxazole; AMP =
ampicillin; CHL = chloramphenicol; NAL = nalidixic acid; CIP = ciprofloxacin
’+’ indicates ‘and’
The results presented are based on data interpreted using CLSI clinical
breakpoints
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614 (75%) isolates, to ciprofloxacin in 605 (74%) isolates,
to co-trimoxazole in 563 (69%) isolates, to ampicillin in
533 (65%) isolates, to chloramphenicol in 332 (41%)
isolates, to nalidixic acid in 246 (30%) isolates. Eleven
isolates (1.3%) showed wildtype susceptibility to all
tested antibiotics. The MIC values for ciprofloxacin sus-
ceptibility testing are shown along with the ECOFF and
CLSI clinical breakpoints for ciprofloxacin in Figure 1.
Discussion
This is the first community-based study in Vietnam to
explore the prevalence of antibiotic resistance and their
determinants in commensal E. coli. It increases the lim-
ited knowledge of the prevalence of resistance to differ-
ent antibiotics that are found in a rural population in a
lower middle income country. A study of 113 children
from rural areas around Hanoi conducted between
1996-1999 found similar resistance prevalences for co-
trimoxazole, ampicillin and ciprofloxacin [10]. Compari-
sons between these studies are limited by differences in
methodologies (we used CLSI interpretative breakpoints,
whereas the authors in the previous study followed stan-
dards set by the Swedish Reference Group for antibio-
tics), and that the majority of children in this previous
study had diarrhoea, whereas most children in our study
did not (95% vs. 1% presence of diarrhoea).
A more recently published study in urban Hanoi
examined resistance exclusively in diarrhoeagenic sero-
types of E. coli in a mixture of children with diarrhoea
in hospital and healthy children from daycare and
healthcare centres, with no differences found in resis-
tance prevalences between the two groups [32]. Com-
pared with our study, that study reported higher
Table 3 Summary of resistance prevalence according to
sociodemographic factors and antibiotic use among 818
isolates of E.coli from children aged 6-60 months in
FilaBavi, Vietnam
Prevalence of resistance %
AMP SXT TET CHL NAL CIP
Age
6-23 months 73* 73* 76 46* 30 0.3
24-60 months § 59 64 74 37 24 0.2
Household economic status
Below average 67 68 78 40 24 0.3
Average and above § 64 68 72 41 29 0.2
Geographical area
Lowland 60 66 68* 41 30 0.0
Highland 73 67 78 43 27 0.4
Mountains § 62 72 78 39 23 0.4
Any reported antibiotic use in
prior 21 days
No 56 63 73 37 23 0.6
Yes 72 72 76 44 30 0.0
*Result was statistically significant using binomial logistic regression
§Reference group used in binomial logistic regression
Abbreviations used: TET = tetracycline; SXT = co-trimoxazole; AMP =
ampicillin; CHL = chloramphenicol; NAL = nalidixic acid; CIP = ciprofloxacin
The results presented are based on data interpreted using CLSI clinical breakpoints
Figure 1 Distribution of results from antibiotic susceptibility testing. The results presented are based on data interpreted using CLSI clinical
breakpoints. Abbreviations: S = Susceptible, I = Intermediately susceptible, R = Resistant (using CLSI clinical breakpoints); ECOFF =
Epidemiological cut-off value breakpoint.
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68%), ampicillin (86% vs. 65%), chloramphenicol (77%
vs. 40%), and ciprofloxacin (4% vs. < 1%), but a lower
prevalence of resistance to nalidixic acid (19% vs. 27%).
These differences may reflect higher levels of access and
use of antibiotics in the urban setting. The prevalences
identified in children in FilaBavi are considerably higher
for most antibiotics than the few reported rural commu-
nity studies in other areas of Southeast Asia, including
Thailand and Indonesia [10,11]. Reports from commu-
nity studies in rural areas in India and Peru have also
presented lower prevalences of resistance in commensal
E. coli than identified here [15,16].
Compared with children aged 24-60 months, isolates
taken from children aged 6-23 months had higher pre-
valences of resistance to co-trimoxazole, ampicillin and
chloramphenicol. This is in keeping with a few previous
reports which have suggested that age can act as a risk
factor for carriage of resistant bacteria, independent of
increased antibiotic use of younger children [13,33]. The
higher prevalence of ampicillin resistance in the high-
land area may be partly explained by a higher propor-
tion of children taking beta lactam antibiotics in this
area than in the other areas. Living in the lowland areas
was independently associated with isolates having a
lower prevalence of tetracycline resistance, a drug which
should not be administered to children. This may reflect
previously lower use of tetracyclines within the lowland
area, or differences in exposure of E. coli to tetracylines
from other sources, such as agriculture.
The majority of antibiotic use in our study was for the
treatment of acute respiratory tract illnesses [22]. Analy-
sis of specific antibiotic use showed that the antibiotics
most commonly taken by the children, beta-lactams and
sulphonamides, were strong risk factors for carriage of
ampicillin and co-trimoxazole resistant isolates, respec-
tively. This highlights the importance of individual anti-
biotic use in selecting for carriage of resistant E. coli.
Some studies have failed to find associations between
antibiotic use and resistance in commensals in commu-
nity settings, which may reflect important differences in
methodologies employed, such as not analysing by use
of specific antibiotic classes [16,34,35]. Our data show a
trend towards higher prevalence of co-trimoxazole and
ampicillin resistance in isolates from children who took
sulphonamide and beta-lactam antibiotics, respectively,
in the seven days prior to sampling, compared with chil-
dren who only took these antibiotics between eight and
twenty-one days prior to sampling. Both of these sub-
groups remained significantly higher than children
unexposed to these antibiotics during the study period.
CLSI criteria are used to identify bacteria that demon-
strate resistance to antibiotics in a clinical setting,
whereas ECOFF values are designed to identify bacteria
that show reduced susceptibility to an antibiotic, as
compared with the wildtype population of bacteria. Ana-
lysis of decreased susceptibility according to EUCAST
ECOFF values produced comparable results for most
antibiotics to those reached through the use of the CLSI
clinical breakpoints. This reflects the similarity in the
CLSI clinical breakpoint values and the EUCAST
ECOFF values for E. coli. However, a considerable dif-
ference was observed for ciprofloxacin. Whereas 0.2%
and 2.7% isolates were resistant or intermediately sus-
ceptible, respectively, using CLSI clinical breakpoints,
74% of isolates were found to have decreased suscept-
ibility compared with the wildtype population, according
to EUCAST ECOFF value. As few studies have thus far
presented comparisons between the prevalence of
decreased susceptibility using ECOFF values and the
prevalence of clinical resistance using CLSI breakpoints,
interpretation of this result must be made cautiously. It
is possible that this represents an emerging decrease in
susceptibility of E. coli in the study area to fluoroquino-
lones. A study by de Jong et al. also found significant
differences between clinical resistance and decreased
susceptibility to ciprofloxacin in commensal E. coli iso-
lates from healthy food-producing animals in Europe,
however the magnitude of the difference was less than
that found in our study [36]. The EUCAST ECOFF
value for ciprofloxacin in E. coli is based on 17877
observations [37], from which a similar definition of the
wildtype population was reached using a normalized
resistance interpretation method [38].
We identified a prevalence of EHEC carriage of 5%,
which meant it was the dominant diarrhoeagenic E. coli
subtype in our study. Two studies have found similar pre-
valences of EHEC carriage in asymptomatic individuals,
one in workers from meat processing plants in Switzerland
[39], and another in families living on dairy farms in
Canada [40]. This high level of carriage might come from
the large number of farm animals present in Bavi, or from
other environmental sources, which we have not
attempted to investigate in the present study. It may be
that this high prevalence is due to a clonal spread, which
could be explored in further studies. EHEC carriage was
not associated with presence of any gastrointestinal symp-
toms, and its clinical significance remains unclear.
Our community study of resistance in commensal
bacteria has several strengths, including its size and high
response rate. The daily reporting of antibiotic use, vali-
dated by weekly follow up interviews, have enabled ana-
lysis of individual drug use to be correlated with
antibiotic resistance, and suggested a trend towards
higher resistance when antibiotics were consumed close
to the date of sampling. There are also a number of lim-
itations to our study. Importantly, only one E. coli iso-
late from each child was tested for antibiotic
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coli strains usually co-exist in an individual’sg a s t r o i n -
testinal tract [17,41]. The true prevalence of carriage of
resistant E. coli is consequently likely to be higher than
the figures presented here.
A further limitation is that the analysis on antibiotic
use counted all days on which antibiotics were taken as
equivalent, assuming that full doses had been taken. It
has been noted elsewhere that sub-therapeutic dosing
may be common in low- and middle-income countries
[15]. Our study did not assess the contribution of cer-
tain potential exposures to antibiotics and antibiotic
resistant bacteria remarked on elsewhere: antibiotic use
by household members, day care attendance, exposure
to contaminated water sources, contact with animal
microflora. We have not investigated the prevalence of
different mechanisms underlying the resistant pheno-
types presented here.
Conclusions
Our study has identified high prevalences of resistance
to individual antibiotics in commensal bacteria isolated
from children in a rural area of northern Vietnam. The
high prevalences of resistance seen after individual anti-
biotic use highlight the increasing threat posed by anti-
biotic resistance in Vietnam, and suggest further
evidence for the need for commitment to ensuring anti-
biotics are used in as rational a manner as possible.
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